The Sedona Conference WG9/WG10 Patent Litigation Working Groups 2017 Annual Meeting

The Sedona Conference WG9/WG10 Patent Litigation Working Groups 2017 Annual Meeting

Speaking Engagement

WG9 and WG10 has several ongoing and newly launched Commentary drafting projects in process, including on:

  • WG10 Chapter on Parallel USPTO Proceedings ("Stage Two" - from the perspective of USPTO Patent and Trial Appeal Board (PTAB) litigation)
  • WG10 Chapter on Multi-District Litigation and "Pseudo-MDLs"
  • WG10 Section on Willful Infringement in light of Halo Electronics
  • WG10 Chapter on International Trade Commission Section 337 Patent Litigation
  • WG10 Chapter on Biopharma Litigation
  • WG9 Commentary on Case Management of Patent Damages and Remedies Issues
  • WG9 Section on Patent Damages Hearings
  • WG9 Commentary on Standard-Essential Patents and FRAND Issues

Join the dialogue to bring these commentaries, with their principles and best practice recommendations for a better patent system, toward true non-partisan, consensus-based publication in the true Sedona fashion.

WilmerHale Partner Andrea Weiss Jeffries will speak on the trade secrets panel and will moderate the panel "Whether damages-focused hearings can be used relatively early in the case to focus the litigation" and WilmerHale Partner Mark Selwyn will speak on the panel "FRAND and SEP - Effective case management to focus the issues and advance the litigation."

Read More About the Event

Speakers

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.